Profiling Diverse Compounds by Flux- and Electrophysiology-Based Primary Screens for Inhibition of Human Ether-à-go-go Related Gene Potassium Channels-Reference-Cited by-同舟云学术

Profiling Diverse Compounds by Flux- and Electrophysiology-Based Primary Screens for Inhibition of Human Ether-à-go-go Related Gene Potassium Channels

Published:2010-12 Issue:6 Volume:8 Page:743-754
ISSN:1540-658X
Container-title:ASSAY and Drug Development Technologies
language:en
Short-container-title:ASSAY and Drug Development Technologies

Author:

Zou Beiyan¹,Yu Haibo¹,Babcock Joseph J.¹,Chanda Pritam²³,Bader Joel S.²³,McManus Owen B.¹²,Li Min¹²

Affiliation:

1. Department of Neuroscience, High Throughput Biology Center, Johns Hopkins University, Baltimore, Maryland.

2. Johns Hopkins Ion Channel Center (JHICC), Johns Hopkins University, Baltimore, Maryland.

3. Department of Biomedical Engineering, School of Medicine, Johns Hopkins University, Baltimore, Maryland.

Publisher

Mary Ann Liebert Inc

Subject

Drug Discovery,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/adt.2010.0339

Reference40 articles.

1. Therapeutic Approaches to Ion Channel Diseases

2. Ion Channels as Drug Targets: The Next GPCRs

3. How many drug targets are there?

4. G-Protein-Coupled Receptors: From Classical Modes of Modulation to Allosteric Mechanisms

5. Targeting proteases: successes, failures and future prospects

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of a Small Molecule Activator of Slack (Kcnt1) Potassium Channels That Significantly Reduces Scratching in Mouse Models of Histamine‐Independent and Chronic Itch;Advanced Science;2024-02-13

2. Prediction and Experimental Evaluation of the hERG Blocking Potential of Drugs Showing Clinical Signs of Cardiotoxicity;Letters in Drug Design & Discovery;2022-08-04

3. A High-Throughput Screening Assay to Identify Drugs that Can Treat Long QT Syndrome Caused by Trafficking-Deficient K_V11.1 (hERG) Variants;Molecular Pharmacology;2022-02-06

4. Current development of integrated web servers for preclinical safety and pharmacokinetics assessments in drug development;Briefings in Bioinformatics;2020-08-07

5. VU0810464, a non‐urea G protein‐gated inwardly rectifying K + (K ir 3/GIRK) channel activator, exhibits enhanced selectivity for neuronal K ir 3 channels and reduces stress‐induced hyperthermia in mice;British Journal of Pharmacology;2019-05-30